Emsam (Transdermal)
Generic name:selegiline (transdermal route) [ se-LE-ji-leen ]
Drug classes:Dopaminergic antiparkinsonism agents, Monoamine oxidase inhibitors
Medically reviewed by Drugs.com. Last updated on Mar 25, 2022.
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.Selegiline transdermal patch is contraindicated in patients less than 12 years of age because of an increased risk of hypertensive crisis .
Commonly used brand name(s)
In the U.S.
- Emsam
Available Dosage Forms:
- Patch, Extended Release
Therapeutic Class: Antidepressant
Pharmacologic Class: Monoamine Oxidase Inhibitor, Type B
Uses for Emsam
Selegiline skin patch is used to treat mental depression in adults. This medicine is a monoamine oxidase inhibitor (MAOI).
This medicine is available only with your doctor's prescription.
Before using Emsam
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated any benefit to using selegiline skin patch in children with depression. Studies have shown that some children, teenagers, and young adults think about suicide or attempt suicide when taking this medicine. Because of this toxicity, use in children is not recommended.
Selegiline skin patch should not be used in children younger than 12 years of age.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of selegiline skin patch in the elderly.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
<..